Suppression of principal atherosclerotic mechanisms by prostacyclins and other eicosanoids

Prog Lipid Res. 1986;25(1-4):645-66. doi: 10.1016/0163-7827(86)90132-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Arteriosclerosis / metabolism
  • Arteriosclerosis / prevention & control*
  • Blood Platelets / drug effects
  • Cholesterol / metabolism
  • Epoprostenol / therapeutic use
  • Humans
  • Hyperplasia / metabolism
  • Mitogens / metabolism
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / pathology
  • Prostaglandins / therapeutic use*

Substances

  • Mitogens
  • Prostaglandins
  • Cholesterol
  • Epoprostenol